| Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray CP Hans, DD Weisenburger, TC Greiner, RD Gascoyne, J Delabie, G Ott, ... Blood 103 (1), 275-282, 2004 | 4903 | 2004 |
| Tumor-associated macrophages and survival in classic Hodgkin's lymphoma C Steidl, T Lee, SP Shah, P Farinha, G Han, T Nayar, A Delaney, ... New England Journal of Medicine 362 (10), 875-885, 2010 | 1465 | 2010 |
| MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy KJ Savage, NA Johnson, S Ben-Neriah, JM Connors, LH Sehn, P Farinha, ... Blood, The Journal of the American Society of Hematology 114 (17), 3533-3537, 2009 | 795 | 2009 |
| MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 692 | 2011 |
| Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL) P Farinha, H Masoudi, BF Skinnider, K Shumansky, JJ Spinelli, K Gill, ... Blood 106 (6), 2169-2174, 2005 | 574 | 2005 |
| Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ... Journal of clinical oncology 33 (26), 2848, 2015 | 442 | 2015 |
| Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma LT Lam, G Wright, RE Davis, G Lenz, P Farinha, L Dang, JW Chan, ... Blood, The Journal of the American Society of Hematology 111 (7), 3701-3713, 2008 | 411 | 2008 |
| Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma D Ennishi, A Jiang, M Boyle, B Collinge, BM Grande, S Ben-Neriah, ... Journal of Clinical Oncology 37 (3), 190, 2019 | 322 | 2019 |
| Helicobacter pylori and MALT lymphoma P Farinha, RD Gascoyne Gastroenterology 128 (6), 1579-1605, 2005 | 294 | 2005 |
| The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL W Ci, JM Polo, L Cerchietti, R Shaknovich, L Wang, SN Yang, K Ye, ... Blood, The Journal of the American Society of Hematology 113 (22), 5536-5548, 2009 | 270 | 2009 |
| Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma P Farinha, RD Gascoyne Journal of Clinical Oncology 23 (26), 6370-6378, 2005 | 256 | 2005 |
| Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition D Ennishi, K Takata, W Béguelin, G Duns, A Mottok, P Farinha, ... Cancer discovery 9 (4), 546-563, 2019 | 248 | 2019 |
| Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma AH Banham, JM Connors, PJ Brown, JL Cordell, G Ott, G Sreenivasan, ... Clinical Cancer Research 11 (3), 1065-1072, 2005 | 244 | 2005 |
| The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation P Farinha, A Al-Tourah, K Gill, R Klasa, JM Connors, RD Gascoyne Blood, The Journal of the American Society of Hematology 115 (2), 289-295, 2010 | 234 | 2010 |
| Histological transformation and progression in follicular lymphoma: a clonal evolution study R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ... PLoS medicine 13 (12), e1002197, 2016 | 230 | 2016 |
| High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology DW Scott, RL King, AM Staiger, S Ben-Neriah, A Jiang, H Horn, A Mottok, ... Blood, The Journal of the American Society of Hematology 131 (18), 2060-2064, 2018 | 225 | 2018 |
| Prognostic factors in follicular lymphoma T Relander, NA Johnson, P Farinha, JM Connors, LH Sehn, ... J Clin Oncol 28 (17), 2902-2913, 2010 | 217 | 2010 |
| LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab Y Natkunam, P Farinha, ED Hsi, CP Hans, R Tibshirani, LH Sehn, ... Journal of Clinical Oncology 26 (3), 447-454, 2008 | 206 | 2008 |
| Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL KJ Savage, GW Slack, A Mottok, LH Sehn, D Villa, R Kansara, R Kridel, ... Blood, The Journal of the American Society of Hematology 127 (18), 2182-2188, 2016 | 196 | 2016 |
| Gene expression–based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma DW Scott, FC Chan, F Hong, S Rogic, KL Tan, B Meissner, S Ben-Neriah, ... Journal of Clinical Oncology 31 (6), 692, 2013 | 195 | 2013 |
